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Abstract
Glucocorticoids are a class of steroid hormones that can either be produced synthetically or
naturally by the adrenal glands. The synthetic glucocorticoids are highly prescribed in the United States
for their anti-inflammatory and immunosuppressive properties to treat a variety of ailments and diseases;
however, these have been implicated in a number of adverse human conditions such as obesity,
metabolic syndrome, immune-suppression, delayed puberty, adrenal insufficiency and Cushing
Syndrome, among others. Ongoing research has shown that synthetic and natural hormones are
transported to aquatic environments via mammalian excretion or wastewater effluent, and as a result, the
release of glucocorticoids into the environment is potentially creating reproductive stress and mutations
on aquatic vertebrates. The occurrence of glucocorticoids in environmental samples has only been
reported worldwide in limited articles; nonetheless the studies have led to growing awareness of their
potential environmental and health impacts at low concentrations ng/L. Their effects in the environment
are unknown; however, the aforementioned compounds in water resources are of increasing concern due
to their ability to act as endocrine disruptors.
Given that synthetic and natural estrogens have been previously found in wastewater influent and
effluent for the Paso Del Norte Region, we hypothesized that glucocorticoids would be detected at
significant concentrations. The objective of this research was to develop and optimize a chemical and
biological method for the detection of glucocorticoids using solid phase extraction (SPE) followed by
high performance liquid chromatography mass spectrometry (HPLC-MS)—in addition to a biological
analysis using a 4-hour yeast assay.
Four glucocorticoids were included in this study and they are cortisone, hydrocortisone,
prednisone and prednisolone. The average glucocorticoid concentrations in influent and effluent ranged
from 4.62 (prednisolone/cortisone) to 15.56 (prednisone) ng/L, and from 3.43 (prednisolone/cortisone)
vi

to 12.57 (prednisone) ng/L, respectively.

Prednisone had the highest levels among the four

glucocorticoids in all wastewater samples potentially reflecting a high consumption of prednisone for
asthma and allergy treatments in our region. Wastewater samples were collected at different time of the
day, 8:00 a.m., 12:00 p.m., and 6:00 p.m. The averages of the total glucocorticoids (i.e. sum of the four
compounds) were 33.25 (±6.37), 24.20 (±3.54), 20.87 (±0.77) ng/L and effluent: 20.09 (±1.63) ng/L
24.23 (±6.38) ng/L, and 19.46 (±0.99) ng/L for 8:00a.m, 12:00p.m., and 6:00p.m. samples, respectively.
For the influent samples, the finding showed that the levels of glucocorticoid in the morning hour
samples were higher than that in samples collected from the rest of the day. As for the effluent samples,
glucocorticoids are higher in the 12 pm samples. A 17.9 (±9.7) % estimated removal for the Northwest
Wastewater Treatment Plant was calculated. To date, research has not identified a specific technology or
wastewater treatment process that has the potential to completely remove glucocorticoids from
wastewater effluent however anaerobic treatment is highly recommended.
Two previously hGR transfected yeast cells were tested for detecting glucocorticoids in
wastewater: one with a higher promoter activity (MCY-212) in comparison to a lower promoter activity
yeast cell (DSY-1345). The half maximal effective concentrations, EC50, for the glucocorticoids of
interest were found to be in the µM range which is equivalent to high mg/L concentration. The results
indicated that the biological analysis is not a suitable method for analyzing glucocorticoid activity in
wastewater since the sensitivity of the assay was not sufficient for samples with concentrations of ng/L
levels.
Even though this research was focused on the Paso Del Norte region, the presence of
glucocorticoids in the environment is a worldwide problem. Semi-arid and arid regions represent 30% of
the world’s continental area. Limited water resources have the potential to be highly impacted by
anthropogenic activities. It is important to target the removal of glucocorticoids and other environmental
endocrine disruptors during wastewater treatment processes to avoid further dispersal of these
vii

contaminants of emerging concern to freshwater systems and protect the water resources for the safety
of public health.
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Chapter 1: Introduction
In the past century, population growth and industrial development have assisted in the creation of
anthropogenic substances that could be harmful to human health and environment. A group of these
compounds, —also known as endocrine disrupting compounds (EDCs), natural and man-made, can
interfere with the function of the endocrine system potentially inducing adverse effects in humans and
wildlife. Most of these compounds are found in everyday products—such as pharmaceuticals, personal
care products, plastics, and food products containing residuals of agricultural chemicals. Much attention
has been given to synthetic and natural steroid hormones, which even are found at small concentrations
in the environment, but can consequently mimic endogenous hormones by binding to the receptor and
blocking, altering, or mimicking the response. Steroid hormones are transported through the
environment from human excretion and veterinary application in farming fields potentially leach into
groundwater and sewage treatment effluents (Figure 1) (1) (2) (3). Wastewater from municipal sources
is recovered and treated while veterinary waste is introduced into the environment directly through urine
and manure. Urine is the primary source for environmental steroids while feces carry negligible
concentrations (4) (5).
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not apply to the detection of EDCs in the environment nor the removal of EDCs from wastewater
treatment processes (8).
Studies have shown that the ecotoxicological effects of EDCs on vertebrates include disruptions
in metabolism, reproductive, endocrine, and immune system henceforth affecting development (9).
Exposures to estrogens in clinical and toxicological studies have shown altering the behavior in terms of
fitness, survival and population level outcome for various types of fish (10) (11) (12). Alongside
estrogens, androgenic and anti-androgenic compounds also have a strong presence in aquatic systems
and they have been shown biological activity in the micromolar range for rivers in Italy (13). The
synthetic androgen, 17β-trenbolone (TB), used in livestock as an anabolic steroid, has been found in
receiving waters from livestock effluent—posing an ecological risk and potentially leading to
masculinization of fish in that area (14). Androgens have shown to be the dominant endocrine disruptors
in comparison to progestogens and estrogens in wastewater effluent in China (15). While the majority of
studies for EDCs focus on sex steroid hormones such as estrogen and androgen, the dangers posed by
another class of steroid hormones, glucocorticoids, have not been fully understood or studied. Little is
known about new emerging compounds and their chemical transformation as they travel through the
environment—posing a threat to wildlife, human health and the integrity of water quality. The scientific
community has mainly focused on identifying their existence in the environment by tracing their
occurrence, fate, and transport in the environment and assessing the physiological effects they pose on
vertebrates in aquatic ecosystems.

Paragraphs with the styles Heading 1,h1 or Heading 2,h2 applied can be extracted to appear in
the
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1.1

Glucocorticoids

As mentioned before, most research regarding steroid hormones mainly focus on sex steroids,
specifically: 17β-trenbolone (TB), 17β-estradiol (E2), estrone (E1) and estriol (E3) and contraceptive
17α-ethinylestradiol (EE2) (14) (16). Therefore, knowledge on a class of steroid hormones, known as
glucocorticoids, in environmental matrices is limited. While estrogens and androgens induce changes in
sex organs, glucocorticoids have the ability to affect many physiologic, metabolic and immunologic
processes due to their ability to express in every cell in the body. Glucocorticoids are produced by the
adrenal glands and bind to the glucocorticoid receptor (GR) forming the activated GR complex, and .are
essential in regulation and maintenance of physiological processes such as cardiovascular, metabolic,
immunologic and homeostasis development.
Cortisone and cortisol are steroid hormones naturally produced by the body while prednisone,
hydrocortisone, prednisolone, dexamethasone, budesonide, and triamcinolone acetonide are synthetic
drugs that are used to treat ailments such as asthma, allergies, osteoporosis, inflammatory diseases and
veterinary purposes. In Great Britain, the glucocorticoid prescriptions have increased by 34% in the last
two decades (17). For the U.S, several corticosteroid prescription drugs have made it to the 200 top RX
drug list (Table 1) (18). Not all glucocorticoid require a prescription and are commonly found in drug
stores to treat inflammatory ailments. Popular non-prescription glucocorticoids include hydrocortisone
cream (Eumovate™ Cream) used for temporary relief of skin irritation, eczema, insect bites among
other skin ailments. It should be noted that despite their therapeutic properties, glucocorticoids have
been implicated in the advent of various health conditions, both mental/psychological and a variety of
metabolic disorders (19).
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Table 1 Corticosteroids found in Top 200 Prescribed list for 2009 in the United States (18)
Drug

Properties

Nasonex (64)

Anti-Inflammatory

Deltasone (50)

Antineoplastic Agents,
Hormonal
Anti-Inflammatory
Immunosuppressant

Advair Diskus (76)

Anti-Inflammatory

Medrol (107)

Anti-Inflammatory
Anti-Inflammatory
Immunosuppressant
Anti-Inflammatory
Immunosuppressant

Tobradex
Ciprodex Otic

1.2

Compound
Mometasone furoate
monohydrate
Prednisone

Disease
Hay fever
Allergic reaction
disorders

Fluticasone
propionate
Methyl Prednisolone

Asthma
(COPD)

Dexamethasone

Eye Infection

Dexamethasone

Ear Infection

Analytical Methods for Steroid Hormones

With the high consumption of pharmaceuticals and high production of commercial chemicals it
is important to determine the transport and fate of these compounds in the environment with the help of
chemical and biological analytical methods. The science behind analytical methods provides the
experimental design and framework from sample collection to sample analysis where identification and
quantification of synthetic and natural chemical components can be achieved. Biological based methods
are promising in a way that a holistic effect can be measured through its toxicological potential in a
biological system, while analytical identification exhibits sensitivity and precision regarding the
compound specificity in an environmental sample. Analytical methods that measure the occurrence and
concentration of steroid hormones in environmental samples consist of purification and analyte isolation
by extraction and concentration, followed by chromatographic separation where identification and
quantitation is achieved through mass spectrometric analysis. This research is focused on analytical and
biological methods for detection of pharmaceuticals in wastewater.
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1..2.1

Curreent Chemicaal Methods

The detection of steroid hormones can be pperformed w
with gas cchromatograaphy/mass
spectrometry (GC-MS)) and high performancce liquid chhromatograpphy (HPLC)) coupled w
with mass
spectrometry (MS) or fluorescence
f
(20) (21) (2
22). Sample preparationn for steroid hormones uusing GCMS is time--consuming due to a deerivatization step; the prreferred method for theese compounnds is LC
which combines solid phase extrraction (SPE
E) for sampple cleanup and extracction (2) (115). Mass
spectrometric analysis is
i the most common method
m
used to detect, iddentify and quantitate m
molecules.
Many timess, the combin
nation of HP
PLC and MS is not suff
fficient to prrovide enouggh resolutionn thus the
coupling of two or moree mass analy
yzers, i.e. tan
ndem mass sppectrometerrs are used inn complex m
matrices.
heory, the separation of steroid
s
horm
mones is baseed on the phhysicochemiccal characterristics and
In th
functional groups
g
with
hin a moleccule and thee proper coombination of mobile and stationaary phase
affecting thee separation
n based on polarity (Figu
ure 2). In SP
PE, the analyytes of interrest and the unwanted
matrix are filtered thrrough hydro
ophobic and
d hydrophiliic interactioons with thhe end prodduct of a
concentrate of target an
nalytes, mak
king the chem
mical analysis more effficient, less time consum
ming, and
overall succcessful.

Figure 2 Po
olarity spectrum of analy
ytes and the mobile and stationary phases in liquuid chromatoography
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HPLC can be coupled to electron spray ionization (ESI) or atmospheric pressure chemical
ionization (APCI) mass spectrometry. The ESI ionization is a soft method that allows less fragmentation
of compound and is best suited for highly polar, non-volatile compounds. The analytes in the eluting
solvent are introduced into the MS after a HPLC unit; high voltage is applied to create ultra-fine charged
droplets; and as they disperse, the solvent evaporates increasing the electric field of the droplet. These
droplets generate a protonated or deprotonated molecule that is then detected by the mass spectrometer.
In comparison to ESI, APCI is suitable for low and medium polarity compounds. In this study, a
reverse-phase SPE and HPLC-ESI-MS using Agilent 1100 coupled to the AccuTOF JMS-T100LC was
used to perform the analysis of glucocorticoids in wastewater samples collected from local wastewater
treatment facilities.
1.2.2

Current Biological Methods

In a biological method, the total biological effect is assessed. The principle of a bioassay is to
compare biological activity produced a sample to a pharmaceutical standard, ultimately providing a
quantitative estimation of the pharmaceutical’s equivalent effects on living organisms. Depending on the
analyte or biologic reaction of interest, the transfection of a responsive gene can be manipulated into
yeast, mammalian, bacterial and plant cells. Well-known methods for the detection of estrogenic
compounds based on the yeast-cell and mammalian cell model have been used for the detection of
estrogenic, androgenic, and glucocorticoid activity in environmental samples (23) (24). In the yeast cell,
S. cerevisiae, expression plasmids, receptor construct and reporter construct of specific hormone are
introduced (25) (26). Expression plasmids include human estrogen receptor alpha (hERα), human
estrogen receptor beta (hERβ), human androgen receptor (hAR), human progesterone receptor beta
(hPRB) and human glucocorticoid receptor alpha (hGRα) coinciding with the correct ligand and receptor
activating transcription in DNA (27). Reporter genes are also transfected into the yeast genome to
measure the activity of the transfected gene i.e. hER, in the yeast population. Common reporter proteins
7

include β-Galactosidase, green fluorescent proteins and luciferase (28) (29). Recombinant yeast assay
are robust, specific and suited to test characteristics of pure compounds (30). The limit of detection
range for yeast assays are likely to be found at the low micromolar range while some can be detected in
the picomolar range. In comparison, mammalian assays incorporate human cells with a transfected
reporter gene but do not require plasmid transfection. In this type of assay, the cell culture preparation
can take up to three days. After cell culture preparation, the cells are placed in 96-well in a steroid-free
medium with the sample for an exposure period ranging from 24 hours to 5 days. Known estrogenic
mammalian assays include ER-CALUX, MELN, T47D-KBlunc and E-Screen which incorporates T47D
breast cancer cell, MCF-7 breast cancer cell, breast cancer T47D, and breast cancer cells MCF-7BOS,
respectively (23). All mammalian assays follow a well-known protocol with a difference in sample
exposure period ranging from 16 hours to 5 days. Mammalian assays are broadly used for biologic
studies and are known to be highly sensitive and versatile; however, as aforementioned, they are also
highly complex. Constraints include high costs, intense labor, time consuming and sterilization of cells
prior to use and high risk for contamination. Mammalian cell based assays are recommended as initial
screening tools to detect estrogenicity with an LOD in the picomolar to low nanomolar range (31).
In this project, the yeast estrogen screen (YES) method was used. The yeast cell S. cerevisiae is
transfected with hGR and a reporter gene, i.e. lac-Z-gene, into the cell’s genome. The glucocorticoid
presence activates hGR inducing expression of the lac-Z gene. Substrates are added to produce βGalactosidase, which is then measured by a spectrometer.

8

1.3

Wastewater Treatment Processes

A wastewater treatment plant (WWTP) constitutes a collection of structures designed to treat
biological and chemical impurities in water promoting the re-use and recycling of wastewater. However,
in the past 20 years, studies have reported that removal of pollutants in wastewater has not been
completely accomplished by conventional water treatment (32) (33) (34). Studies carried out in Austria,
Brazil, Canada, Croatia, England, Germany, Greece, Italy, Spain, Switzerland, The Netherlands and the
U.S., have shown more than 80 compounds ranging from pharmaceuticals to drug metabolites detected
in the aquatic environment (35).
The conventional design for wastewater treatment encompasses preliminary treatment, primary
treatment, secondary treatment, and tertiary treatment in addition to residual management. Each WWTP
is unique in the way that it is designed to treat certain volumes while combining different technologies
for secondary and tertiary treatments, which are determined, based on industrial and agricultural
processes occurring in the area. The Environmental Protection Agency (EPA) establishes water quality
guidelines and regulations for surface and drinking water. These regulations prohibit certain pollutants
from reaching WWTP or surface waters for more than 50 different industrial industries. These laws
ultimately regulate point sources; however, they do not address regulatory effluents for emerging
compounds in wastewater effluent.

As the name implies, “emerging compounds” do not have

established regulatory status and could potentially impact the environment and human health (36).
In this study, wastewater samples were collected from Northwest Wastewater treatment plant
located in the west side of El Paso, Texas. The Northwest Wastewater Treatment plant treats 17.5
Million Gallons per Day (MGD) of industrial and residential wastewater and releases its effluent into the
Rio Grande (37). The treatment process and sampling locations for this study are illustrated in Figure 3.
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Figgure 3 North
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1.4

Research Objectives

The objectives of this research were to:
(1) Optimize a chemical and biological method for the detection of glucocorticoids using solid
phase extraction (SPE) followed by liquid chromatography mass spectrometry (LC-MS)—in
addition to a 4-hour yeast assay.
(2) Apply these methods to detect the occurrence, concentrations and bioactivity of glucocorticoids
in wastewater.

The presence of glucocorticoids in the environment is a worldwide problem. This study will
serve to highlight the potential problems in water management in areas with limited water resources.
The Paso Del Norte region along the U.S.-Mexico border shares resources as well as environmental
problems. Recycling and reusing treated water is becoming a necessary practice in areas with limited
surface and ground water resources; maintaining the integrity of treated water is critical for protecting
human health and the environment. This research is the first study conducted for the Paso Del Norte
region--an international border, to address the presence of glucocorticoids in wastewater treatment
plants and their impact on the environment.

11

Chapter 2: Methodology
Glucocorticoid standards (cortisone, hydrocortisone, prednisone and prednisolone (purity ≥ 98%)) were
purchased from Sigma Aldrich (St. Louis, MO, USA). Methanol (HPLC grade) was purchased from
Fisher Scientific (Waltham, MA, USA). Standards were prepared at a concentration of 1000 mg/L in
100% methanol and stored at -20 °C to minimize evaporation and degradation.
The manufacturers and part number of the material used in this research is as follows: OASIS HBL SPE
cartridges (Part No. 186000117) by Waters (Milford, MA, USA); Atlantis® T3 3µm 2.1x150mm
Column (Part No. 186003719) and corresponding guard column Symmetry® C18 5µm 3.9x20mm (Part
No. WAT054225) (Milford, MA, USA), GF/F Whatman Glass Microfibre filter (70 mm) from Voigt
Global Distribution Incorporated (Lawrence, Kansas, USA) (Part No. 1825070).

2.1

HPLC-MS Parameters and Operating Conditions

The natural and synthetic glucocorticoids chosen for this study were chosen based of their
occurrence in environmental samples from various worldwide studies (

Cortisone

Hydrocortisone

Prednisolone

Prednisone

(Natural)

(Synthetic)

(Synthetic)

(Synthetic)

C21H28O5

C21H30O5

C21H28O5

C21H26O5

360.44 g/mol

362.46 g/mol

360.44 g/mol

358.42 g/mol

Chemical
Formula
Molecular
Weight
12

Molecule

Table 2) (38) (39). The EPA Method 1694: Pharmaceutical and Personal Care Products in Water,
Soil, Sediment and Biosolids by HPLC-MS/MS was used as a starting foundation for the development
of the chemical analysis for glucocorticoids in environmental samples. For the HPLC method, EPA
method involves reverse-phase chromatography utilizing a C18 HPLC column and a gradient method
using mobile phases (A) LC-MS Grade Water and (B) 100% LC-MS grade Acetonitrile with 0.1%
Formic Acid. In this study, several isocratic HPLC methods were tested using 0%B, 50%B and 100% B
from the EPA Method, in addition to Methanol with 0.1% Formic Acid (
Table 3). The aim of the HPLC method is to achieve complete separation and distinguish distinct
ion signatures (m/z) for cortisone and prednisolone in addition to an efficient elution time.

Table 2 Natural and synthetic glucocorticoids for this study

Cortisone

Hydrocortisone

Prednisolone

Prednisone

(Natural)

(Synthetic)

(Synthetic)

(Synthetic)

C21H28O5

C21H30O5

C21H28O5

C21H26O5

360.44 g/mol

362.46 g/mol

360.44 g/mol

358.42 g/mol

Chemical
Formula
Molecular
Weight

Molecule
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Table 3 HPLC isocratic methods attempted for the detection of glucocorticoids in wastewater

Attempt:
1
2
3
4

B)
0.1% Formic
Acid in
LC-MS grade
Acetonitrile
0%
50%
100%

A)
0.1% Ammonium
Formate in LCMS grade water
100%
50%
0%

2.1.1

C)
0.1% Formic
Acid in LCMS grade
Methanol
---100%

HPLC-MS Run

Target compounds were analyzed by Agilent 1100 (Agilent Technologies) equipped with a
degasser, a binary pump and auto sampler. The chromatographic separation was completed by Atlantis®
T3 3µm 2.1x150mm column with corresponding guard column SENTRY® C18 3µm 2.1x20mm. The
column oven temperature was at ambient temperature and the injection volume was 15 uL. An isocratic
elution using HPLC Methanol with 0.1% Formic Acid was applied at a flow rate of 0.150 ml/min. Prior
to analysis, the column and corresponding guard cartridge were conditioned and equilibrated with 5mL
of the mobile phase solution.
Mass spectrometry analysis was performed using AccuTOF JMS-T100LC with ESI+ mode. The
MS operating conditions were set to as follows: MS Acquisition Method was set as:
gas temperature, 250 °C; Orifice1 80 °C; Needle Voltage, 2000V; Orifice1 Current, 223nA; Rings lens
voltage, 10V; Orifice 1 Voltage, 70V; and Orifice 2 Voltage, 5V.
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2.2

Solid Phase Extraction (SPE)

All one-liter wastewater samples were filtered through GF/F Whatman Glass Microfibre filter
(70 mm) and pH adjusted with hydrochloric acid to 2.5. The OASIS cartridges were placed onto the SPE
apparatus (Supelco Visiprep Large Volume Sampler: 57275) connected to a vacuum and filtering flask
(EYELA Aspirator) and filtering flask (2000 mL Kimax Filtering Flask), which allowed the sample to
filter through the OASIS cartridge (Oasis HBL, 6mL and 500mg each) at a flow of 5-10mL/min. Each
OASIS cartridge was pre-conditioned with 10mL of MeOH, followed by 10mL of HPLC grade water
never allowing the cartridge to reach a dry state. The wastewater samples were then introduced at the
same rate onto the OASIS cartridge followed by a rinse with 50 mL of 5% (v/v) methanol in HPLC
grade water and dried for 2 hours under vacuum. The target compounds were eluted using 12 mL of
ethyl acetate and dried under a nitrogen flow. The dried samples were reconstituted to 100 uL of
methanol for instrumental analysis.
The sample cleanup and HPLC conditions for this study were initially selected according to the
EPA Method. The initial attempt involved EPA Method 1694 reverse phase chromatography; however,
no response was obtained leading to further modification of the elution solvent (Table 4). According to
literature review for environmental glucocorticoids, the elution solvent typically used for the extraction
of glucocorticoids in environmental samples is ethyl acetate (2) (15). In the second SPE attempt,
methanol was substituted with ethyl acetate and same volume was maintained.
Table 4 SPE methods attempted in this research for a glucocorticoid recovery
(2)
(3)
(1)
Sample
Method
Conditioning
Cartridge
PreSolvent
Treatment
WATERS
20 ml MeOH
EPA 1694
-Filtration
15

(4)
Wash
6ml reagent

(6)
(5)
EluateRecovery
Elution
Post
Treatment
12 ml

Concentration

NA

HBL OASIS

EPA 1694
(Modified)

Liu et al.
Method

WATERS
HBL OASIS

WATERS
HBL OASIS

-pH =2.0
-EDTA
-Filtration
-pH =2.0
-EDTA

+
6ml DI water

water
+ 5 min dry

methanol

with N2 Flow

10 ml MeOH
+
6ml DI water

6ml reagent
water
+ 5 min dry

12 ml
ethyl
acetate

Concentration
with N2 Flow

NA

-Filtration
-pH =2.0

10 ml MeOH
+
10 ml HPLC
water

50 ml of 5%
MeOH in
HPLC grade
water
+ 2 hour dry

12 ml
ethyl
acetate

Concentration
with N2 Flow

71+/- 0.98%

NA= Not available

The main problem encountered for the first two SPE methods were cartridge clogging and
inability to completely process the 1-liter sample. This method was then compared to other SPE
glucocorticoid methods where ethyl acetate was used as the elution solvent followed by a second SPE
process for each sample which led to <90% recoveries (Figure 4) (15) (38).
In the third attempt, the method was optimized following literature SPE methods for extraction
of glucocorticoids in wastewater; however, eliminated the secondary SPE method. In comparison to the
EPA: 1694 method, literature methods excluded the addition of ethylenediaminetetraacetic acid
(EDTA), a chelating agent, and included a 50mL of HPLC grade wash and 2-hour cartridge drying
under vacuum. The SPE test was completed using literature method Liu et al., specific for 1-liter
wastewater samples, while excluding the secondary SPE process (Figure 4) (38).
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method.
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Table 5 Con
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o glucocortiicoid cocktaiil solution annd the amouunt spiked to the blank foor SPE
recovery teest to achieve a final volu
ume of 1 mgg/L
Soluttion

Stock

Spiked volume
v
in 10000
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Final

Extraact

Glucocorticoid
cocktail

Standard
(mg/L)

mL blank (μL)

Concentration
(mg/L)

volume (μL)

5

20

1

100

2.3

Bioassay

In this research, a previously established four-hour yeast assay for estrogenic activity was
implemented and optimized for glucocorticoid receptor activity. Two previously hGR transfected yeast
cells were used; compared for optimization, one with a higher promoter activity (MCY-212) while in
comparison to a yeast cell (DSY-1345) exhibiting lower promoter activity.
Standard solutions of the individual glucocorticoids were prepared in ethanol (Table 6). All
steroid hormones were prepared as a 10mM stock solution in ethanol and the positive control,
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deoxycorticosterone (DOC), was prepared as a 20mM stock solution in ethanol. Initial and final
concentrations are represented in a 1:100 dilution. All stock solutions were stored at a -4°C.
Table 6 Standard dilutions for glucocorticoids ranging from 50nM to 10mM (1:100 dilution)

Initial
0
50 nM
100 nM
500 nM
1 mM
5 mM
10 mM
50 mM
100 mM
500 mM
1 mM
5 mM
10 mM

2.3.1

Final
Log Units (Final)
0
01.00 E-10 (arbitrary)
0.5 nM
5.00E-10
1 nM
1.00E-09
5nM
5.00E-09
0.01 M
1.00E-08
0.05 M
5.00E-08
0.1mM
1.00E-07
0.5mM
5.00E-07
1 mM
1.00E-06
5 mM
5.00E-06
0.01 mM
1.00E-05
0.05 mM
5.00E-05
0.1 mM
1.00E-04

Four-Hour Yeast Assay Protocol

The yeast were grown in freshly prepared media containing histidine and lucine amino acids and
lacking uracil and tryptophan (SC-UW), at 30 °C in a shaking water bath. The liquid media was
prepared using a pre-prepared 1-yeast media soluble 4X-concentrated SW-UW solution, with 375mL
Milli-Q autoclaved water, in addition to 1mL of each: Histidine and Lucine. Culture tube is incubated
overnight in a 30°C incubated shaker, leaving the lid open allowing air exchange.
The next day, the spectrometer warmed up for at least 20 minutes at 600nm. Using the
appropriate cuvettes, a blank using fresh liquid media SC-UW was used to calibrate the spectrometer,
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followed by
y optical density (O.D) measurement
m
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Figure 7 Waastewater inffluent and efffluent flow for the Nortthwest Wasteewater Facillity (Million gallons
of incomin
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Cha
apter 3: Results and
d Discussioon
3.1.1 Chemical Analysis: H
HPLC Meth
hods
The main goal of
o the chemiccal analysis was
w to creatte a method tthat identifiees the signatture of the
nd mass-to-ccharge ratio (m/z) signatture. The moost difficult challenge
analytes bassed on retention time an
for the anallysis of gluccocorticoids is the similar moleculaar signaturee of the analytes, speciffically for
prednisolone and cortiso
one which sh
hare the exacct molecularr weight, havve similar strructure
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Table 2) and retention times in HPLC-MS identification. As shown in Table 7, the retention
times for mobile phase A, B, C and D do not show significant separation with a difference in retention

Cortisone

Hydrocortisone

Prednisolone

Prednisone

(Natural)

(Synthetic)

(Synthetic)

(Synthetic)

C21H28O5

C21H30O5

C21H28O5

C21H26O5

360.44 g/mol

362.46 g/mol

360.44 g/mol

358.42 g/mol

Chemical
Formula
Molecular
Weight

Molecule

time ranging from 0-0.4 minutes and an average +/-0.2 minute separation. These tests demonstrated that
alternating the composition of the mobile phase will not improve the separation of glucocorticoids of
interest and therefore isocratic solvent system (i.e. constant composition) was used in this study. Mobile
phase D showed the highest elution strength and was chosen for this study based on the shorter
acquisition time and clean spectra response, in comparison to other methods.
Table 7 Retention times for glucocorticoids using four different isocratic mobile phases
Mobile Phase
A

Analyte

100%
LC-MS Grade
Water,
0.1% Formic
Acid
RT (min)

B
(1:1, v/v)
(A)
LC-MS Grade Water,
0.1% Formic Acid
(B)
100% ACN LC-MS
Grade,
0.1% Formic Acid
RT (min)
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C

D

100%
ACN LC-MS
Grade,
0.1% Formic
Acid

100%
MeOH LC-MS
Grade,
0.1% Formic Acid

RT (min)

RT (min)

Cortisone
Hydrocortisone
Prednisone

4.4
4.6
4.4

4.7
4.9
4.7

5.7
5.7
5.5

3.6
3.6
3.3

Prednisolone

4.8

4.6

5.7

3.7

The retention times for methods A, B, C and D are in agreement with literature research for the
analysis of environmental glucocorticoids (Table 8). All studies utilize a C18 column as a stationary
phase and a polar solvent as mobile phase. While most studies utilize LC-MS grade water and
acetonitrile as mobile phases, in this study, methanol was determined to be the strongest eluent with
shorter retention times. It should be noted that the separation of these glucocorticoids was poor in all
studies.
Table 8 HPLC literature methods for glucocorticoids
Analytes
Of
interest

Column
Dimensions

Mobile Phase

LC-MS
system

Retention
Time (min)

Reference:

CR
CL
PRL
PRN
+ 18 others

ACQUITY BEHC18
(50mm* 2.1mm,
1.7μm)

Gradient
A-Water
+0.1%FA
B-ACN +0.1%FA

UPLCMS

CR- 2.9
CL-2.8
PRL-2.8
PRN-2.8

(40)

CR- 5.5
CL-5.4
PRL-5.0
PRN-4.9

(41)

CR- 4.9
CL-5.4
PRL-5.4
PRN-4.7

(15)

CR
CL
PRL
PRN
+ 2 others
CR
CL
PRL
PRN
+ 3 others
CL
PRL
+ 1 other
CL
PRN
+ 1 other

Zorbac Eclipse
XDB-C18
(50mm X 4.6mm,
1.8µm)
UPLC BEH C18
column
(100X 2.1mm,
1.7µm)
RP Gemini C18
column
(50mm X 4.6mm,
5µm)
Supelco Supelcosil
ABZ + PLS
(3 mm×150 mm, 3
µm)

Gradient
A(Water/ACN) 78:22
+0.1%FA
B(MeOH/ACN) 78:22
+0.1%FA
Gradient
AWater +0.1%FA
BMeOH

LCMS/MS

LCMS/MS

Isocratic
(3:1) ACN/ Water
+ 0.1% FA

LCMS/MS

Gradient
AAmmonium Acetate
B-

LCMS/MS
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CL-4.0
PRL-3.9

(65)

6-9.5min

(43)

MeOH
CR
CL
PRL
PRN

Atlantis T3 Column
(2.1 X 150 mm,
3µm)

Isocratic
MeOH
+ 0.1% FA

CR- 3.6
CL-3.6
PRL-3.7
PRN-3.3

LC-MS

This
research

CR=Cortisone; CL=Hydrocortisone; PRL=Prednisolone; PRN=Prednisone; ND=no data
3.1.2

Chemical Analysis of Glucocorticoids: HPLC-MS Identification

The analysis and confirmation for selected glucocorticoids were defined using ESI positive mode
which led to the addition of a protonated molecule [H+] to each target analyte during mass spectrometry
analysis (Figure 8). All samples (calibration standard, SPE recovery test, and wastewater sample
analysis) were analyzed at a specific retention time range (3.3-4.3 minutes) and specific analyte ions
signature based on their mass-to-charge ratio (m/z). Selected Ion Monitoring mode (SIM) was used for
mass spectra identification where a specific m/z ratio for each glucocorticoid (Table 9) was monitored.
SIM is recognized as a sensitive analysis method as opposed to SCAN Mode in which every m/z
signature in the sample injection is plotted.

Table 9 Identification and confirmation criteria of analytes in mass spectra
Retention Time

ESI + Mode

Compound

(min)

Signature (m/z)

Cortisone

3.6

361.16- 361.50

Hydrocortisone

3.6

363. 16- 363.50

Prednisone

3.3

359.16- 359.50

Prednisolone

3.7

361.16- 361.50
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Time (min)

Intensity (4573)

[M]

343.2214

4000

361.2340

+1
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0
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Figure 8 Chromatogram and mass spectra of target analytes
in 1 mg/L glucocorticoid standard solution
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3.1.3

Quantitative Analysis

In this study, glucocorticoids were quantified individually except for cortisone and prednisolone
which two compounds share the exact molecular signature and similar retention time. Standard
calibration curves were created for individual prednisone and hydrocortisone, combined prednisolone
and cortisone; in addition to a cocktail (i.e. mixture of all four glucocorticoids) solution. Prior to
constructing the calibration curves, a preliminary study was conducted where the cocktail and individual
solutions were injected through the HPLC-MS to determine the lowest concentration that the mass
spectrometer could detect in the sample. This preliminary work led to the construction of calibration
curves with concentrations ranging from 0.1 to 1 mg/L, (standard concentrations 0.1, 0.2, 0.4, 0.6, 0.8,
1.0 mg/L) where concentration was plotted against corresponding peak area for each analyte. The
standard calibration curves were used to determine the linear range of detection by the time-of-flight
mass spectrometer for quantification purposes. All HPLC-MS runs were completed in triplicates with a
10-minute acquisition time and a 2-minute column equilibration time. Linearity for individual
calibration curves for hydrocortisone, prednisolone and cortisone, prednisone and cocktail solution
reached correlation coefficients of 0.96, 0.99, 0.99, and 0.98 respectively, as shown in Figure 9.
Individual calibration curves for individual compounds are listed in Appendix A.
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Cocktail Solution

R² = 0.97705
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Figure 9 Calibration curve for glucocorticoid cocktail solution (Peak area (detection response) vs.
Concentration)
3.1.4

Chemical Analysis: HPLC-MS Validation

The limit of detection (LOD) and limit of quantitation (LOQ) were calculated based on the
signal-to-noise ratio (SNR). The LOD and LOQ are defined as the smallest measure that can be detected
and quantified with reasonable certainty by an instrument of by using a specific method. LOD and LOQ
values for standard calibration curves were calculated using the EXCEL function STEYX and slope, as
shown in Equation 1 and Figure 10. The function STEYX measures the standard error of the predicted
Y-value for each X in a regression. The LOD and LOQ were calculated according to standard curves
for all analytes. The quantification method for the analysis of target analytes is summarized in Table 10.
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Equation 1 Equations used to calculate LOD and LOQ for glucocorticoids using calibration curve, slope
and EXCEL software.

(1)

LOD = (STEYX / Slope) X 3.3

(2)

LOQ = (STEYX/ Slope) X 10

Figure 10 Example of LOD and LOQ calculation using EXCEL

Table 10 Summary for chemical validation and quantification methods

0.96
0.99

LOD
(mg/L)
0.28
0.22

LOQ
(mg/L)
0.87
0.67

y= 581324x +18862
y= 586788X -15947

0.99

0.16

0.50

y=1186859x -8338

0.98

0.19

0.59

y= 2E+06x + 83517

Compound

R2

Hydrocortisone
Prednisone
Prednisolone+
Cortisone
Cocktail
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Equation

3.2

SPE Recovery Test

The recovery test was completed under the established methods in this study as shown in Figure
11. Using the standard curve for cocktail solution, cocktail solution was spiked to 1 L of DI water to
reach a final concentration of 1 mg/L in the final 100 µL extract. The extract was analyzed for
glucocorticoids based on m/z identification and retention time of 3.3-4.3 minute range using SIM mode.
Table 12 shows the average recovery for total glucocorticoid, i.e. the sum of all four analytes. The SPE
recovery for a 1 mg/L final extract from in a 1-liter sample resulted in a 67 ±0.01% recovery.

Table 11 SPE recovery test results
Recovery %
Peak Area for SPE Test 1

0.67

Peak Area for SPE Test 2

0.68

Peak Area for SPE Test 3

0.67

Average Recovery

67 ±0.01%
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3.3.1

Environmental Concentrations

Concentrations of four glucocorticoids, prednisone, hydrocortisone, prednisolone and cortisone
in wastewater were determined by HPLC/MS. Prednisolone and cortisone were combined due to their
identical m/z value and retention time. All target analytes were present in all the influent and effluent
samples (Table 12 and Table 13). Individual glucocorticoid concentrations in the influent ranged from
2.3 to 19.0 ng/L while glucocorticoid concentrations in effluent ranged from 2.7 to 14.4 ng/L. The most
prominent glucocorticoids in influent and effluent samples were as follows: prednisone>
hydrocortisone> prednisolone/cortisone.

These natural and synthetic glucocorticoids can be

metabolized and excreted through urine or washed off from the skin at different rates. The higher level
of prednisone in wastewater influent samples could be a result of it being a highly prescribed
medication. Prednisone has biological half-life of several hours and 1-hour metabolism rate from the
body (44). Its metabolite is prednisolone which is also found in the wastewater samples. Prednisone is
commonly used for asthma, rheumatic disorders, allergic disorders, and among other diseases. In this
study, prednisone concentrations in wastewater samples remain pretty constant in the influent samples
collected from different time. The samples were collected during the month of October, a month known
where many seasonal changes occur and this might suggest the high use of prednisone to treat seasonal
allergies. Cortisone, prednisolone and hydrocortisone concentration in influent trends also did not vary
much throughout the day. Prescribed prednisolone medications require a follow up of several dosages
and these results might correlate with continued dosages. Cortisone is naturally produced in the body
and the highest levels are produced in naturally in the morning. One constraint in this study was that our
method is not able to differentiate between natural cortisol and synthetic prednisolone and therefore not
allowing us to hypothesize about the potential sources. Hydrocortisone is easily obtained over the
counter therefore introducing higher variability in concentrations as shown in sampling day 2 with a
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15.41 ng/L when compared to sampling day 1 (9.84 ng/L) and sampling day 3 (4.74 ng/L) morning
samples.
The total concentrations of the four glucocorticoids in the influent samples show a range from 20
to 38 ng/L while glucocorticoid effluent concentrations range from 18 to 31 ng/L. Though it is not
statistically significant, the glucocorticoid concentrations in the influent show a trend in which
concentrations are at its highest in the morning and decrease as the day continues (Table 14). This
observation supports the renal excretion of glucocorticoids and it might suggest that most of the
glucocorticoid pharmaceuticals are mainly consumed in the morning.

No particular trend of

glucocorticoid level was noticed in the effluent.
Table 12 Glucocorticoids Concentrations (ng/L) in Wastewater Influent Samples
Influent Sampling Time

Day 1

Day 2

Day 3

Hydrocortisone

Prednisolone/Cortisone Prednisone

Total

8:00 a.m.

9.84

6.80

19.06

35.70

12:00 p.m.

4.97

5.78

15.92

26.67

6:00 p.m.

2.33

4.01

14.00

20.34

8:00 a.m.

15.41

4.15

18.47

38.03

12:00 p.m.

5.61

4.84

15.32

25.78

6:00 p.m.

3.15

3.79

13.58

20.52

8:00 a.m.

4.74

5.42

15.86

26.01

12:00 p.m.

2.90

3.36

13.88

20.15

6:00 p.m.

4.39

3.42

13.95

21.76
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Table 13 Glucocorticoids Concentrations (ng/L) in Wastewater Effluent Samples
Effluent Sampling Time

Day 1

Day 2

Day 3

Hydrocortisone

Prednisolone/Cortisone Prednisone

Total

8:00 a.m.

2.74

3.52

12.32

18.58

12:00 p.m.

14.39

3.70

13.50

31.59

6:00 p.m.

3.30

3.29

11.76

18.35

8:00 a.m.

3.35

3.16

13.37

19.88

12:00 p.m.

4.72

3.38

12.50

20.60

6:00 p.m.

4.86

3.33

12.05

20.24

8:00 a.m.

4.91

3.88

13.03

21.81

12:00 p.m.

4.34

3.41

12.73

20.49

6:00 p.m.

4.69

3.23

11.88

19.80

Table 14 Average Concentration of Glucocorticoids (ng/L) in Influent and Effluent Samples by the time
of the day
Sampling
Time

Influent

Hydrocortisone

Prednisolone/Cortisone

Prednisone

Total

8:00 a.m.

10.00

5.46

17.80

33.25

12:00 p.m.

4.49

4.66

15.04

24.20

6:00 p.m.

3.29

3.74

13.84

20.87

8:00 a.m.

3.67

3.52

12.90

20.09

12:00 p.m.

7.81

3.50

12.91

24.23

6:00 p.m.

4.29

3.28

11.89

19.46

Effluent
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Table 15 Total Average Concentrations (ng/L) of Glucocorticoids. Data are presented as Average ±
standard deviation
Hydrocortisone Prednisolone/Cortisone

Prednisone

Influent n=9

5.93 ± 4.18

4.62± 1.18

15.56± 2.02

Effluent n=9

5.26 ± 3.52

3.43± 0.23

12.57± 0.64

Glucocorticoid concentrations found in this study were within the range of ppt or ng/L as
published by other studies (Table 16). The glucocorticoid influent concentrations in this study were
comparable to those in China of which were found to be within 0.5 to 40 ng/L range.
All three studies conducted in China and the study in Spain show that glucocorticoid
concentration in influent wastewater range from 1 to 190 ng/L for cortisone and hydrocortisone while
prednisone and prednisolone range from 1.7 to 25 ng/L. The effluent glucocorticoid concentrations for
the studies in China show that cortisone, hydrocortisone and prednisone were still found at low ng/L
concentrations in effluent water. In this study, the glucocorticoid effluent concentrations are higher than
those reported in literature with average concentrations ranging from 3.43 to 12.57 ng/L.
The studies conducted in the Netherlands and Spain show higher glucocorticoid concentrations
in influent in comparison to this study and China’s study. This comparison reflect that the levels of
glucocorticoid in the environment could be depending on surrounding industrial sources which could
cause the concentrations of glucocorticoids to be as high as in the µg/L range (45). To date, there is no
literature that addresses the occurrence of environmental throughout the day. This is the first study that
addresses environmental glucocorticoid occurrence in influent and effluent wastewater samples at
different times of a sampling day.
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Table 16 Literature review for chemical analysis of glucocorticoids in environmental matrices
Results (ng/L)

Sample
Location

Method

Ref:

Matrix

China

China

Spain

China

CRN

PRL

PRN

CRL

SPE-LC-ESI-

Influent

30.53

3.02

2.62

39.3

Chang et

MS/MS

Effluent

0.26

0.56

0.18

0.51

al. 2009

SPE-LC-ESI-

Influent

1.0

1.7

0.56

15.6

Chang et

MS/MS

Effluent

0.13

0.07

0.06

0.24

al. 2007

SPE-UHPL-

Influent

135

25

<20

190

Herrero et

ESI-MS/MS

Effluent

n.d

n.d

n.d

<10

al. 2012

SPE-LC-ESI-

Influent

14.5

--

--

12.7

Liu et al.

MS/MS

Effluent

n.d

--

--

n.d

2011

LC-MS/MS

Influent

381-472

315-1918

117-545

275-301

Wastewater

Wastewater

Wastewater

Wastewater

The

Hospital

Netherlands

wastewater

Hungary

River water

Schriks et
al 2010

SPE-LC-API-

A

--

--

--

<0.17-0.36

Tolgyesi

MS/MS

B

--

0.04-0.58

--

0.32-2.67

et al. 2010

CRN=Cortisone; CRL=Hydrocortisone; PRL=Prednisolone; PRN=Prednisone; ND=no data

To date, there is limited information of the risks that environmental glucocorticoids pose to the
ecosystem. Those studies mostly focused on the effects of fish to high dietary glucocorticoid exposures
and have found that glucocorticoids could inhibit aggressive behavior, immunological response and
locomotor activity in rainbow trout (46). Only one in-vivo study has evaluated environmentally relevant
concentrations of synthetic glucocorticoids and their effects on aquatic organisms (47). In the study
conducted by Kugathas et al., fish were exposed to synthetic glucocorticoids, prednisolone and
beclomethasone dipropenate. The tests evaluated potential physiological changes by measuring plasma
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glucose levels and leucocyte counts. The results revealed that glucose level concentrations for the
exposure of both synthetic glucocorticoids significantly increased in comparison to the control group.
Increased plasma glucose levels are associated with hyperglycemia which is known for creating
problems in the eyes, kidneys, nerves and blood vessels. The results also revealed that the glucocorticoid
exposed groups had a reduced total leucocyte count or white cell counts which are known as diseasefighting cells. In addition, the finding indicated that increased plasma glucose levels and the effects
were dose-dependent ---greater at higher concentration (10 µg/L). Other studies have confirmed that
cortisol administration to fish elevates the plasma glucose up to 3-fold depending on the concentration
(48). These studies suggest that environmentally relevant concentrations can affect aquatic organisms
and highlight the point that effects are concentration dependent.
The study by Kugathas et al. highlights the importance for future studies to address the effects of
glucocorticoids as a whole rather than to consider their individual effects to aquatic organisms. In this
study, the total glucocorticoid concentrations in the effluent were found to have an average of 21.3 ng/L
(Figure 12). Such level could potentially induce ecotoxicological effects when present in aquatic
ecosystems even though they would not be considered high enough to induce physiological changes as
shown in Kugathas study.
Daily Sampling Total Concentration
Concentration (ng/L)

30
25
20
15

Average Influent

10

Average Effluent

5
0
Day 1

Day 2

Day 3

Figure 12 Total Glucocorticoid Concentrations (ng/L) in the Influent and Effluent from Different
Sampling Dates.
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3.3.2

Estimated Removal

It is evident that the degradation and elimination of glucocorticoids in the wastewater treatment
process are incomplete (Table 15). The removal of glucocorticoids by the treatment processes is
estimated using the differences between the average total glucocorticoid in the influent and effluent.
The estimated removals of glucocorticoids for sampling day 1, 2 and 3 were 17.2%, 28% and 8.6%,
respectively, as shown in Table 17. The total average estimated removal is 17.9 (± 9.7) %.
Table 17 Estimated Glucocorticoid Removal
Total
Day 1

Day 2

Day 3

Average Influent

27.57

28.11

22.64

Average Effluent

22.84

20.24

20.70

Estimated Removal %

17.2

28.0

8.6

Removed

17.9 ± 9.7%

The detection of glucocorticoids in effluent might be due to metabolism and transformation of
glucocorticoids in the complex wastewater matrix. Compounds with similar structures to those of
glucocorticoids have previously shown the ability to transform in wastewater and surface water, e.g.
estradiol to estrone (49). Chemical transformation of environmental glucocorticoids is unknown as there
are no existing databases that track their transformation in the environment (50). It is important to
identify what wastewater treatment is needed to remove glucocorticoids and other EDCs from
wastewater processes.
Studies in China have attempted to understand the biological degradation of estrogens,
androgens, progestogens and glucocorticoids during wastewater treatment processes. The studies found
that the highest degradation, which have shown glucocorticoid removals of 92-100%, occur during the
secondary processes with a combined treatment of anaerobic-anoxic-aerobic units (15). Mass changes
39

of glucocorticoid through combined treatment of anaerobic-anoxic-aerobic units have shown to that
anaerobic positively contributed to the degradation of hydrocortisone, cortisone and prednisone with a
87%, 70% and 74% removal, respectively (15).
Not all wastewater facilities, including the Northwest Wastewater Treatment facilities are
equipped with the combination of these units. The Northwest facility treats wastewater with pressurized
air in the aeration process and anoxic and anaerobic units are not present which could have led to the
inability to completely remove glucocorticoids from effluent as shown in this study.
To date, research has not identified a specific technology or wastewater treatment process that
has the potential to completely remove glucocorticoids from wastewater effluent however the anaerobic
treatment is highly recommended. Alternate secondary treatment and processes are available, i.e.
activated sludge and biofiltration, in wastewater treatment; however, some are more effective for
reducing estrogenic compounds and do not eliminate completely (51) (52) (53). Other common
secondary treatment processes include coagulation, flocculation, and precipitation and have shown to be
ineffective for the removal of endocrine disrupting compounds (54) (55). Other studies focused on
tertiary treatment technologies and their ability to degrade steroid hormones (56) (57). Tertiary
processes are mainly used for disinfection purposes, i.e. UV-light disinfection, chlorination, ozone or
activated carbon and it is unknown how they specifically affect glucocorticoid removal during
wastewater treatment. Activated carbon has shown to remove a large percentage of organic micro
pollutants; however, it is highly complex as it depends on carbon type, contact time, contaminant
solubility, and greater affinity than natural organic matter in wastewater (58) (59). These units are not
found in many wastewater treatment facilities consequently, resulting in residual EDC concentrations in
drinking water, surface water, wastewater effluent and sediment (60) (61) (62) (63).
Even though this research is focused on the Paso Del Norte region, the presence of
glucocorticoids in the environment is a worldwide problem. Semi-arid and arid regions represent 30% of
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the world’s continental area. The cities of El Paso, TX and Juarez, Mexico form the largest metropolitan
area in the world with a population of 2.2 million in an area with limited surface and ground water
resources. Water supply demands are critical and highly implicated by growing populations and
anthropogenic activities. It is important to address the presence of glucocorticoids and other potential
problems related to EDCs in water management in semi-arid areas like Paso Del Norte. There are six
wastewater treatment facilities in the region and the treated water from these plants are released into
irrigation canals or Rio Grande, a river that forms part of the Mexico – U.S. border. It is important to
target the removal of glucocorticoids during wastewater treatment processes to avoid further dispersal to
freshwater systems and protect the water resources for the safety of public health.
3.4

Biological Method

Two previously hGR transfected yeast cells (developed by Dr. Marc Cox) were compared for
method optimization: one with a higher promoter activity (MCY-212) in comparison to a lower
promoter activity yeast cell (DSY-1345). Sensitivity was determined based on the half maximal
effective concentration EC50, which describes a specific concentration that elicits half of the maximal
response. The comparison of dose response curves and EC 50 values for the two stains using a positive
control deoxycorticosterone (DOC) is shown on Figure 13.
The yeast strain DSY-1345 in the dose response curve correlates with lower plasmid expression
in comparison to yeast strain MCY-212 that was transfected with a higher hGR plasmid expression.
EC50 values for both yeast strains rendered response in the micromolar range and are not significantly
different; however, yeast strain DSY-1345 had better R-squared values and had more consistent
performance; therefore it was chosen in the continuation of this study.
Dose response curves were completed in triplicates for cortisone, hydrocortisone, prednisone and
prednisolone with strain DSY-1345 (Figure 14). Their EC50 values were found within the micromolar
range, excluding hydrocortisone where the EC50 response exceeded the proposed concentration range
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used in this study. Summary of EC50 values for all target analytes using DSY-1345 is shown in Table 13
and the dose response curves are included in Appendix B.

Table 18 EC-50 values for DOC using MCY-212 and DSY-1345
Yeast
Strain
MCY-212
DSY-1345

EC50 (M)

R2

2.38E-06
2.21E-06
1.96E-06
4.58E-06
3.82E-06
4.26E-06

0.62
0.64
0.62
0.70
0.73
0.72

Figure 13 Dose-response curve comparisons for yeast strain DSY-1345 and MCY-212
using positive control DOC
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Figure 14 Dose-response curves using DSY-1345 for target analytes
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Table 19 Summary of EC-50 values for target analytes using yeast strain DSY-1345.

Cortisone
EC50 (M)

Average
mg/L

R2

Hydrocortisone
R2

EC50 (M)

Prednisone

Prednisolone

EC50 (M)

R2

EC50 (M)

R2

4.61E-06

0.87 N.A.

N.A.

3.94E-06

0.8

7.37E-07

0.65

3.74E-06

0.89 N.A.

N.A.

1.17E-06

0.87

5.19E-07

0.60

3.97E-06

0.91 N.A.

N.A.

1.27E-06

0.78

9.02E-07

0.19

4.10E-06

N.A.

N.A.

2.13E-06

1.7

N.A.

0.77

7.19E-07
0.26

N.A. Not applicable
The average EC50 values for each compound were then translated into mg/L. Literature review
has shown that environmental glucocorticoids are present in wastewater influent and possibly in effluent
in the part per trillion ranges (ng/L) (38) (15) (27). Since environmental glucocorticoid concentrations
are expected at low part per trillion ranges, the findings from this study lead to the conclusion that the
biological method in this study is not sensitive enough to detect glucocorticoid activity in municipal
wastewater samples. In addition, the coloration of the extracts was causing interference with the yeast
assay and greatly reduced the application of the bioassay in wastewater analysis (Figure 15). If sampled
wastewater were to be collected from hospital effluent, the yeast assay and mammalian assays would be
a higher probability for biological activity as other studies have demonstrated (29).

Figure 15 The color in wastewater sample extract after SPE
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As previously mentioned, mammalian and yeast cell assays are popular models for the biological
analysis of steroid hormones in environmental samples. There are a limited number of studies that have
reported biological effects of glucocorticoids in environmental matrices (Table 20). Literature shows
that mammalian cell bioassays are the preferred choice for the detection of environmental
glucocorticoids. However, it is still possible for yeast cell assays to biologically detect glucocorticoid
when the concentrations were in high ng/L range as shown by Schriks et al. 2010.
Table 20 Literature review for biological analysis of glucocorticoids in environmental matrices
Type of Assay

Recombinant
yeast cell

GR-CALUX
bioassay

Matrix

Standard
comparison

Standard
comparison

Cell Type

Results

Saccharomyces
cerevisiae,
transfected with
pCDNA3/hGRα
plasmid containing a
full-length cDNA of
hGRα
Human osteoplastic
osteosarcoma U2-OS
cells transfected with
hGRα expression
plasmid and a
luciferase reporter
construct

EC 50 (μM)
CRL=123
CRN=not active
PRL=643
PRN=not active

Ref:

Bovee et al.
2011

EC 50 (nM)
CRL=37
CRN=not active
PRL=12
PRN=not active

Bovee et al.
2011

ng dex EQs/L
Schriks et
al. 2010

GR-CALUX
bioassay

Wastewater

Human osteoplastic
osteosarcoma U2-OS
cells transfected with
hGRα expression
plasmid and a
luciferase reporter
construct

243 +/-32 (industry)
93+/-13 (hospital 1)
609 +/-79 (hospital 2)
38+/-13 (sewage effluent)

CRL=Hydrocortisone; CRN=Cortisone; PRL=Prednisolone; PRN=Prednisone; ND= No data
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Green
fluorescent
protein-tagged
nuclear
receptor
Recombinant
yeast cell

Freshwater

Mammalian cell line,
36171

28% glucocorticoid activity in 105
samples for 14 states in the U.S

Stavreva et al.
2012

Wastewater

Saccharomyces
cerevisiae,
transfected with
hGRα plasmid

EC 50 (μM)
CRL=ND
CRN= ND
PRL= ND
PRN= ND

This research

In a study, five bioassays (yeast estrogen screen, ER-CALUX, MELN, T47D-KBlunc, and ESCREEN) were compared and validated for the detection of estrogenic chemicals in wastewater,
groundwater and freshwater. These biological methods involved yeast and mammalian cell assays and
were compared based of sensitivity, robustness, MQL and reproducibility (Table 21). The mammalian
cell assays were rated in the following order: MQL> sensitivity> robustness=reproducibility>low
maintenance and cost. In comparison, the yeast assay is considered to be cost efficient and reproducible
however, not sensitive, robust or have a good MQL. In addition, inability of interlaboratory
reproducibility was observed by all assays except for yeast assay and E-SCREEN (64). It is apparent
that the bioassays, such as yeast assay, still pose many constraints for the analysis of steroid hormones in
environmental samples.
Table 21 Comparison in performance for the analysis of estrogenic compounds in wastewater between
yeast and mammalian cell models
YES

ER-CALUX
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MELN

KBlunc

E-SCREEN

(Yeast cell)

(Mammalian

(Mammalian

(Mammalian

(Mammalian

cell)

cell)

cell)

cell)

Sensitivity

-

+++

++

++

++

Robustness

-

++

++

++

++

_

+++

+++

+++

+++

++

+++

+

++

++

+++

-

+

+

+

Method
quantification
limit
Reproducibility
Low
maintenance
and cost

Chapter 4: Conclusion
An optimized chemical method using solid phase extraction (SPE) followed by liquid
chromatography mass spectrometry (LC-MS), and a biological analysis using a 4-hour yeast assay were
developed for detection of glucocorticoids in wastewater. The biological analysis used two previously
hGR transfected yeast cells, MCY-212 and DSY-1345, to determine most sensitive strain. Half maximal
effective concentrations for both strains were not significantly different and both strains exhibit a
response in the micromolar range. The yeast strain DSY-1345 was selected for this study due to higher
correlation coefficient for dose-response curves. The effective concentrations for cortisone, prednisone,
and prednisolone resulted in the micromolar range concentrations that transfer to mg/L in environmental
samples. The dose response for hydrocortisone was not completed due to its response exceeding the
proposed concentration range and solubility problems that dealt with higher concentrations. The
biological method in this study did not provide sufficient sensitivity for low glucocorticoid
concentrations expected in the environment.
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The optimization of the chemical method dealt with testing a variety of solvents for solid phase
extraction and mobile phases for chemical analysis. With the chemical method developed, HPLC
parameters and operating conditions were established. SPE recovery tests were completed with a total
recovery of 67 ±0.01%. The glucocorticoids of interest were reported as a group and identified based on
retention time and mass-to-charge ratio signature using selective ion monitoring (SIM).
The second objective was to apply the optimized methods to detect the occurrence,
concentrations and bioactivity of glucocorticoids in wastewater. The chemical method of which
involved sample preparation, extraction method and chemical analysis was applied to 9 influent and 9
effluent wastewater samples from the Northwest Wastewater Treatment Plant located in El Paso, TX.
Glucocorticoid concentrations in the influent and effluent samples were determined for individual and
total glucocorticoid compounds. The average glucocorticoid concentrations of individual target analytes
in the influent samples ranged from 2.3 to 19 ng/L and glucocorticoid concentrations for individual
target analytes in the effluent ranged from 2.7 to 14.3 ng/L. In this study, prednisone was the most
prominent in influent and effluent wastewater samples. These findings might reflect that prednisone is
highly consumed in the region.
The combined glucocorticoid concentrations of target analytes in influent wastewater ranged
from 20 to 38 ng/L, while glucocorticoid concentrations in the effluent ranged from 18 to 31 ng/L. A
trend was observed showing that glucocorticoid concentrations are at its highest in the morning and
decrease as the day continues. This observation might further confirm that most of the glucocorticoid
pharmaceuticals are consumed in the morning, in addition to higher natural production of cortisone in
the morning. This is the first study that addresses the occurrence of glucocorticoids in wastewater at
different times during a sampling day.
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The influent glucocorticoid concentrations found in this study are in agreement with the levels
found in other literature. However, the glucocorticoid effluent concentrations were higher than levels
reported in the literature (0.06 to 0.5 ng/L in China and <10ng/L in Spain).
The estimated removal of glucocorticoids from wastewater treatment processes in the Northwest
Wastewater Treatment facility is 17.9 ± 9.7%. The finding in this research suggests that effluent water
from this facility could be a substantial source of glucocorticoid in the aquatic environment. It is
important to target wastewater treatment processes to avoid aquatic organisms to be exposed to
environmental glucocorticoids. In addition, it is recommended for wastewater treatment processes to
include aerobic-anoxic secondary processes in wastewater treatment facilities. Due to high costs of
implementing new units, the retention time during wastewater treatment processes is a parameter that
could be further researched and modified to enhance further degradation of organic contaminants.

4.1

Future Work

This research serves as a preliminary study for the detection of glucocorticoids in wastewater.
The biological response was not assessed in this study and it is recommended to implement a
mammalian cell assay for the detection of environmental glucocorticoids.

It is also important to

implement analytical instrumentation that is suitable of detecting low levels of glucocorticoids as
expected in environmental concentrations. Though HPLC/MS used in this study was able to obtain some
results, further study may consider tandem MS for better identification of different glucocorticoid
compounds in the environmental samples.
In this study, prednisone was found to be the most dominant glucocorticoids in the sample. The
findings suggest that prednisone could be highly consumed in the west side of El Paso, Texas. Further
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research could be done to determine specific conditions that lead to high consumption of prednisone in
this area.
Another important highlight is that the Northwest Wastewater Treatment Plant is not capable of
removing glucocorticoids from wastewater influent. Future studies can be conducted where the retention
time of secondary and tertiary processes can be modified to determine a suitable time for the removal of
EDCs at this specific facility. This could potentially save millions of dollars since no additional units
would be necessary.
Further studies need to address the in-vitro and in-vivo total effects of glucocorticoids. There is a
need for toxicity studies to determine no observable effect level concentrations (NOEL) so
environmental regulation standards and monitoring can be established in environmental settings. In
addition, it is important educate the public and wastewater treatment personnel on EDCs, their sources,
effects, and daily exposures.
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Appendix A
Calibration curves of the glucocorticoids in this study.
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Hydrocortisone

700

R² = 0.955

Peak Area
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‐
0
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0.4
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0.8

1

1.2
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Calibration curve for glucocorticoid hydrocortisone (Peak area (detection response) vs. Concentration)
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Prednisolone and Cortisone

1,400

R² = 0.988

1,200
Peak Ara

1,000
800
600
400
200
‐
0

0.2

0.4

0.6
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1
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Concentration (mg/L)

Calibration curve for glucocorticoid prednisolone and cortisone (Peak area (detection response) vs.
Concentration)
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Pred
dnisone
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Appendix B
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DSY-1345
EC-50 4.5E-06
2
R 0.70
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400 R 0.73

DSY-1345
EC-50 4.3E-06
2
R 0.72
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Dose response curves for positive control deoxycorticosterone (DOC) using yeast strain DSY-1345
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